Atropine (antidote)
Related FACEM curriculum (2022) learning objectives:
- ME 3.8.1.6(e) Principles of management of toxicological presentations including: Indications for antidotes
- ME 3.8.2.4 Identify the appropriate antidote or antivenom.
Presentations
- Atropine sulfate prefilled syringe: 0.1 mg/mL (10 mL).
- Atropine sulfate ampoules: 0.4 mg/mL, 0.5 mg/mL, 0.6 mg/mL, 1.2 mg/mL.
Toxicological Indications
- Poisoning impairing AV conduction (e.g., cardiac glycosides, beta-blockers, calcium channel blockers).
- Organophosphate and carbamate poisoning.
Contraindications
- Relative contraindications:
- Closed-angle glaucoma.
- Obstructive gastrointestinal disease.
- Obstructive uropathy.
Mechanism of Action
- Competitive acetylcholine antagonist at muscarinic receptors.
- Reverses parasympathetic overstimulation from acetylcholinesterase inhibition.
- No activity at nicotinic receptors.
Pharmacokinetics
- Poor oral bioavailability; hepatic metabolism; 2–4 hour elimination half-life.
- Crosses blood–brain and placental barriers.
- ~50% excreted unchanged in urine.
Administration
General
- Ensure patient is in a monitored area with full resuscitative support available.
Organophosphate and Carbamate Poisoning
- Initial IV bolus: 1.2 mg.
- Repeat every 2–3 minutes, doubling dose until respiratory secretions dry.
- Large doses (up to 100 mg) and continuous infusion may be required in severe cases.
Drug-Induced Bradycardia with AV Conduction Blockade
- Initial IV bolus: 0.6 mg.
- Repeat 0.6 mg doses as needed up to 1.8 mg.
Therapeutic Endpoints
- Drying of respiratory secretions in organophosphate poisoning.
- Excessive dosing indicated by anticholinergic features.
Adverse Drug Reactions
- Anticholinergic poisoning symptoms: delirium, tachycardia, mydriasis, urinary retention.
- Management: stop atropine, use benzodiazepines for delirium, and insert a urinary catheter.
Specific Considerations
- Pregnancy: No restrictions.
- Paediatric Dose: 20 micrograms/kg initial dose.
- Anticipate large atropine doses in organophosphate poisoning; procure sufficient stock early.
Pitfalls
- Inadequate dosing in organophosphate/carbamate poisoning.
- Excessive dosing causing iatrogenic anticholinergic poisoning.